Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical applications of nanomedicines in lung cancer treatment
Mohammad Norouzi, Pierre Hardy
Acta Biomaterialia (2020) Vol. 121, pp. 134-142
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging‐Guided Cancer Radio‐Chemotherapy
Yuan Ding, Zongrui Tong, Lulu Jin, et al.
Advanced Materials (2021) Vol. 34, Iss. 7
Closed Access | Times Cited: 99
Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
Afsana Sheikh, Nabil A. Alhakamy, Shadab Md, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 47
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 45
PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery
Violet V. Sheffey, Emily B. Siew, Eden E. L. Tanner, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 41
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 27
Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer
Sojung Kim, Nidhi Puranik, Dhananjay Yadav, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2659-2676
Open Access | Times Cited: 24
Polymer-based formulations against metastatic non-small-cell lung cancer: A nanotherapeutic approach
Sougata Ghosh, Bishwarup Sarkar
Elsevier eBooks (2025), pp. 635-653
Closed Access
Harnessing Pseudogenes for Lung Cancer: A Novel Epigenetic Target in Diagnosis, Prognosis and Treatment
Yock Young Dan, Xinyi Zhao, Jing Li, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104645-104645
Closed Access
Nano-Based Targeted Drug Delivery for Lung Cancer: Therapeutic Avenues and Challenges
Devaraj Ezhilarasan, Lakshmi Thangavelu, Sreekanth Kumar Mallineni
Nanomedicine (2022) Vol. 17, Iss. 24, pp. 1855-1869
Closed Access | Times Cited: 32
Enhancing Lung Cancer Detection and Classification Using Machine Learning and Deep Learning Techniques: A Comparative Study
Amira Bouamrane, Makhlouf Derdour
(2023), pp. 1-6
Closed Access | Times Cited: 15
Salinomycin-loaded injectable thermosensitive hydrogels for glioblastoma therapy
Mohammad Norouzi, Javad Firouzi, Niloufar Sodeifi, et al.
International Journal of Pharmaceutics (2021) Vol. 598, pp. 120316-120316
Closed Access | Times Cited: 34
Nanoparticle Polymeric Micellar Paclitaxel Versus Paclitaxel for Patients with Advanced Gastric Cancer
Feiyu Wang, Xiangming Huang, Yuqing Cao, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 3, pp. 1105-1110
Open Access | Times Cited: 3
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
Komal Komal, Bibhu Prasad Nanda, L. Singh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9449-9474
Closed Access | Times Cited: 3
Promises of phytochemical based nano drug delivery systems in the management of cancer
Parveen Kumar, Nishant Yadav, Benu Chaudhary, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109745-109745
Closed Access | Times Cited: 26
Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy
Yirivinti Hayagreeva Dinakar, Archana Karole, Shabi Parvez, et al.
Life Sciences (2022) Vol. 310, pp. 121133-121133
Closed Access | Times Cited: 20
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Yiming Xu, Jessica C. Hsu, Liyun Xu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Molecular target identification of two Coleus amboinicus leaf isolates toward lung cancer using a bioinformatic approach and molecular docking-based assessment
Winarto Haryadi, Kasta Gurning, Endang Astuti
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 3
Beyond surface modification strategies to control infections associated with implanted biomaterials and devices - Addressing the opportunities offered by nanotechnology
Da‐Yuan Wang, Linzhu Su, K. A. Poelstra, et al.
Biomaterials (2024) Vol. 308, pp. 122576-122576
Closed Access | Times Cited: 3
Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment
Syed Sarim Imam, Sultan Alshehri, Mohammad A. Altamimi, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 1048-1056
Open Access | Times Cited: 24
Bioorthogonal chemistry-driven anticancer nanotherapeutics
Hongyuan Zhang, Jing Wang, Ruonan Han, et al.
Trends in Chemistry (2023) Vol. 5, Iss. 9, pp. 697-710
Closed Access | Times Cited: 9
PLGA-based drug delivery systems in treating bone tumors
Enduo Qiu, Fei Liu
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 8
Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles
Chandramohan Kiruthiga, Devasahayam Jaya Balan, Nagaiah Hari Prasath, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5131-5144
Closed Access | Times Cited: 2
Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer
Yuanlin Wu, Jiandong Zhang, Junjun Zhao, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Current status and prospects for improved targeted delivery approaches for cancer
Sofiène Mansouri, Yousef Alharbi, Abdulrahman Alqahtani
Pathology - Research and Practice (2023) Vol. 253, pp. 154993-154993
Closed Access | Times Cited: 7
Delivery nanoplatforms based on dynamic covalent chemistry
Fei Lü, Huiwen Zhang, Wei Pan, et al.
Chemical Communications (2021) Vol. 57, Iss. 58, pp. 7067-7082
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top